Squarepoint
BSX icon

Squarepoint’s Boston Scientific BSX Stock Holding History

Squarepoint’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.8M Sell
1,589,914
-1,445,374
-48% -$116M 0.12% 167
2025
Q4 		$289M Buy
3,035,288
+1,200,127
+65% +$118M 0.31% 47
2025
Q3 		$179M Buy
1,835,161
+1,612,916
+726% +$167M 0.18% 110
2025
Q2 		$23.9M Sell
222,245
-560
-0.3% -$56.7K 0.02% 688
2025
Q1 		$22.5M Buy
222,805
+59,950
+37% +$6.04M 0.03% 639
2024
Q4 		$14.5M Sell
162,855
-189,869
-54% -$16.7M 0.01% 935
2024
Q3 		$29.6M Buy
352,724
+244,360
+225% +$19.3M 0.05% 427
2024
Q2 		$8.35M Buy
108,364
+63,420
+141% +$4.64M 0.01% 1041
2024
Q1 		$3.08M Sell
44,944
-13,412
-23% -$862K 0.01% 1809
2023
Q4 		$3.37M Sell
58,356
-66,796
-53% -$3.57M 0.01% 1646
2023
Q3 		$6.61M Sell
125,152
-668,935
-84% -$35.1M 0.02% 1007
2023
Q2 		$43M Buy
794,087
+618,126
+351% +$32.3M 0.13% 162
2023
Q1 		$8.8M Sell
175,961
-13,267
-7% -$625K 0.04% 610
2022
Q4 		$8.76M Buy
+189,228
New +$8.19M 0.03% 563
2022
Q3 		– Sell
-233,404
Closed -$9.36M – 3010
2022
Q2 		$8.7M Sell
233,404
-94,283
-29% -$3.84M 0.05% 448
2022
Q1 		$14.5M Buy
327,687
+287,211
+710% +$12.4M 0.06% 341
2021
Q4 		$1.72M Sell
40,476
-72,277
-64% -$3.04M ﹤0.01% 1352
2021
Q3 		$4.89M Sell
112,753
-156,095
-58% -$6.91M 0.01% 783
2021
Q2 		$11.5M Buy
268,848
+71,513
+36% +$3.01M 0.04% 416
2021
Q1 		$7.63M Sell
197,335
-677,077
-77% -$25.6M 0.04% 458
2020
Q4 		$31.4M Buy
874,412
+427,074
+95% +$15.4M 0.23% 65
2020
Q3 		$17.1M Buy
+447,338
New +$17.2M 0.23% 95
2020
Q2 		– Sell
-578,345
Closed -$18.9M – 2240
2020
Q1 		$18.9M Buy
578,345
+524,914
+982% +$20.5M 0.48% 26
2019
Q4 		$2.42M Buy
+53,431
New +$2.24M 0.01% 797
2019
Q2 		– Sell
-650,110
Closed -$25M – 2383
2019
Q1 		$25M Buy
650,110
+578,510
+808% +$22.1M 0.26% 79
2018
Q4 		$2.53M Buy
+71,600
New +$2.6M 0.03% 603
2018
Q2 		– Sell
-300,395
Closed -$8.21M – 1757
2018
Q1 		$8.21M Sell
300,395
-1,194,401
-80% -$32.5M 0.13% 208
2017
Q4 		$37.1M Buy
+1,494,796
New +$41.2M 0.65% 16
2017
Q3 		– Sell
-583,026
Closed -$16.2M – 1626
2017
Q2 		$16.2M Buy
583,026
+437,636
+301% +$11.6M 0.32% 57
2017
Q1 		$3.62M Buy
+145,390
New +$3.54M 0.1% 249
2016
Q4 		– Sell
-446,654
Closed -$10.6M – 1773
2016
Q3 		$10.6M Buy
446,654
+293,697
+192% +$7.01M 0.71% 17
2016
Q2 		$3.58M Buy
152,957
+35,023
+30% +$758K 0.22% 93
2016
Q1 		$2.22M Sell
117,934
-5,373
-4% -$94.4K 0.17% 150
2015
Q4 		$2.27M Buy
+123,307
New +$2.21M 0.25% 69
2015
Q3 		– Sell
-11,632
Closed -$206K – 419
2015
Q2 		$206K Buy
+11,632
New +$208K 0.07% 368

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Squarepoint's BSX Position: Q1 2026 in Review

Squarepoint reduced its Boston Scientific (BSX) stake by 48% in Q1 2026, selling an estimated $116M and leaving 1,589,914 shares worth $99.8M. The position accounts for 0.12% of the portfolio, ranked #167.

Squarepoint first reported a position in BSX in Q2 2015 and has held it in 35 quarters since. The position peaked at $289M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Squarepoint held 1,589,914 shares of Boston Scientific worth $99.8M as of Q1 2026.
  • Squarepoint sold 1,445,374 Boston Scientific shares in Q1 2026, an estimated $116M.
  • Boston Scientific made up 0.12% of Squarepoint's portfolio in Q1 2026, its #167 holding.
  • Squarepoint first reported a position in Boston Scientific in Q2 2015 and has held it in 35 quarters since.
  • Squarepoint's Boston Scientific position peaked at $289M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.